Rankings
▼
Calendar
RMD FY 2025 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena
RMD
ResMed Inc.
$36B
FY 2025 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$5.1B
+9.8% YoY
Gross Profit
$3.1B
59.4% margin
Operating Income
$1.7B
32.7% margin
Net Income
$1.4B
27.2% margin
EPS (Diluted)
$9.51
Cash Flow
Operating Cash Flow
$1.8B
Free Cash Flow
$1.7B
Stock-Based Comp.
$92M
Balance Sheet
Total Assets
$8.2B
Total Liabilities
$2.2B
Stockholders' Equity
$6.0B
Cash & Equivalents
$1.2B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$5.1B
$4.7B
+9.8%
Gross Profit
$3.1B
$2.7B
+15.1%
Operating Income
$1.7B
$1.3B
+27.7%
Net Income
$1.4B
$1.0B
+37.2%
← Q4 2024
All Quarters
Q1 2025 →